Medrol 16 mg – DIN 00036129
Medrol is Methylprednisolone 16 mg (tablet), sold in Canada. It is used for adrenal insufficiency, multiple sclerosis and ankylosing spondylitis. It is supplied by Pfizer Canada ULC. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Methylprednisolone 16 mg
- Brand
- Medrol
- Strength
- 16 mg
- Used for
- Adrenal insufficiency, multiple sclerosis and ankylosing spondylitis
- Form
- Tablet
- Manufacturer
- Pfizer Canada ULC
- Drug class
- Steroid (corticosteroid)
- Sold in
- Canada
- DIN
- 00036129
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Methylprednisolone used for?
Methylprednisolone is used for adrenal insufficiency, multiple sclerosis, ankylosing spondylitis and lupus.
- Medicine type
- Steroid (corticosteroid)
Official uses from the US prescribing label
Methylprednisolone tablets are indicated in the following conditions:
. Endocrine Disorders
Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance).
Congenital adrenal hyperplasia
Nonsuppurative thyroiditis
Hypercalcemia associated with cancer
. Rheumatic Disorders
As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in:
Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy)
Ankylosing spondylitis
Acute and subacute bursitis
Synovitis of osteoarthritis
Acute nonspecific tenosynovitis
Post-traumatic osteoarthritis
Psoriatic arthritis
Epicondylitis
Acute gouty arthritis
. Collagen Diseases
During an exacerbation or as maintenance therapy in selected cases of:
Systemic lupus erythematosus
Systemic dermatomyositis (polymyositis)
Acute rheumatic carditis
. Dermatologic Diseases
Bullous dermatitis herpetiformis
Severe erythema multiforme (Stevens-Johnson syndrome)
Severe seborrheic dermatitis
Exfoliative dermatitis
Mycosis fungoides
Pemphigus
Severe psoriasis
. Allergic States
Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment:
Seasonal or perennial allergic rhinitis
Drug hypersensitivity reactions
Serum sickness
Contact dermatitis
Bronchial asthma
Atopic dermatitis
. Ophthalmic Diseases
Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa, such as:
Allergic corneal marginal ulcers
Herpes zoster ophthalmicus
Anterior segment inflammation
Diffuse posterior uveitis and choroiditis
Sympathetic ophthalmia
Keratitis
Optic neuritis
Allergic conjunctivitis
Chorioretinitis
Iritis and iridocyclitis
. Respiratory Diseases
Symptomatic sarcoidosis
Berylliosis
Loeffler's syndrome not manageable by other means
Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy
Aspiration pneumonitis
. Hematologic Disorders
Idiopathic thrombocytopenic purpura in adults
Secondary thrombocytopenia in adults
Acquired (autoimmune) hemolytic anemia
Erythroblastopenia (RBC anemia)
Congenital (erythroid) hypoplastic anemia
. Neoplastic Diseases
For palliative management of:
Leukemias and lymphomas in adults
Acute leukemia of childhood
. Edematous States
To induce a diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus.
. Gastrointestinal Diseases
To tide the patient over a critical period of the disease in:
Ulcerative colitis
Regional enteritis
. Nervous System
Acute exacerbations of multiple sclerosis
. Miscellaneous
Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy.
Trichinosis with neurologic or myocardial involvement.
From the FDA-approved label on DailyMed (published Sep 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 00036129.
- It names Medrol, Methylprednisolone 16 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Medrol by Pfizer Canada ULC.
In Canada: prescription only.
Ingredients
Active: Methylprednisolone
Other Methylprednisolone pills
-
42 16 V 4
Methylprednisolone 4 mg
White, oval, 8 mm
Used for adrenal insufficiency and multiple sclerosis
- L13 Methylprednisolone 16 mg White, oval, 10 mm Used for adrenal insufficiency and multiple sclerosis
- CE 190 Methylprednisolone 16 mg White, oval, 10 mm Used for adrenal insufficiency and multiple sclerosis
- 918 Methylprednisolone 16 mg White, oval, 10 mm Used for adrenal insufficiency and multiple sclerosis
- Medrol 16 Methylprednisolone 16 mg White, oval, 10 mm Used for adrenal insufficiency and multiple sclerosis
- L10 Methylprednisolone 2 mg White, oval, 7 mm Used for adrenal insufficiency and multiple sclerosis
- Medrol 2 Methylprednisolone 2 mg White, oval, 8 mm Used for adrenal insufficiency and multiple sclerosis
- CE 187 Methylprednisolone 2 mg White, oval, 7 mm Used for adrenal insufficiency and multiple sclerosis